A mutation in the gamma actin 1 (ACTG1) gene causes autosomal dominant hearing loss (DFNA20/26)
about
Multiphasic analysis of whole exome sequencing data identifies a novel mutation of ACTG1 in a nonsyndromic hearing loss familyALKBH4-dependent demethylation of actin regulates actomyosin dynamics.Rotavirus spike protein VP4 binds to and remodels actin bundles of the epithelial brush border into actin bodies.A mutation of beta -actin that alters depolymerization dynamics is associated with autosomal dominant developmental malformations, deafness, and dystoniaDynamic length regulation of sensory stereociliaAllele-specific effects of human deafness gamma-actin mutations (DFNA20/26) on the actin/cofilin interactionA method for rapidly screening functionality of actin mutants and tagged actinsGenetics of Nonsyndromic Congenital Hearing LossPhenotypic Heterogeneity in a DFNA20/26 family segregating a novel ACTG1 mutation.Evidence for changes in beta- and gamma-actin proportions during inner ear hair cell lifeStructure of the F-actin-tropomyosin complexFinding new genes for non-syndromic hearing loss through an in silico prioritization studyGenetics of auditory mechano-electrical transduction.Actin in hair cells and hearing loss.A locus on distal chromosome 11 (ahl8) and its interaction with Cdh23 ahl underlie the early onset, age-related hearing loss of DBA/2J miceNoncoding mutations of HGF are associated with nonsyndromic hearing loss, DFNB39.Gamma-actin is required for cytoskeletal maintenance but not developmentIn vivo and in vitro effects of two novel gamma-actin (ACTG1) mutations that cause DFNA20/26 hearing impairment.A comparative study of age-related hearing loss in wild type and insulin-like growth factor I deficient mice.β-actin and γ-actin are each dispensable for auditory hair cell development but required for Stereocilia maintenance.Deafness mutation mining using regular expression based pattern matching.Proteomic identification of tumor biomarkers associated with primary gallbladder cancer.ACT-5 is an essential Caenorhabditis elegans actin required for intestinal microvilli formationDelayed embryonic development and impaired cell growth and survival in Actg1 null mice.Distinct functional interactions between actin isoforms and nonsarcomeric myosinsMutations and polymorphisms of the skeletal muscle alpha-actin gene (ACTA1).Inhibition of type I insulin-like growth factor receptor tyrosine kinase by picropodophyllin induces apoptosis and cell cycle arrest in T lymphoblastic leukemia/lymphoma.Genetic insights into the morphogenesis of inner ear hair cells.Pathological situations characterized by altered actin isoform expression.Rapid nucleotide exchange renders Asp-11 mutant actins resistant to depolymerizing activity of cofilin, leading to dominant toxicity in vivoConformational dynamics of actin: effectors and implications for biological function.Non-syndromic hereditary sensorineural hearing loss: review of the genes involved.Insights into the effects of disease-causing mutations in human actins.New treatment options for hearing loss.Baraitser-Winter cerebrofrontofacial syndrome.Synthetic lethal hubs associated with vincristine resistant neuroblastoma.A novel missense mutation in ACTG1 causes dominant deafness in a Norwegian DFNA20/26 family, but ACTG1 mutations are not frequent among families with hereditary hearing impairment.Audiometric and vestibular features in a second Dutch DFNA20/26 family with a novel mutation in ACTG1.Functional characterization of the human α-cardiac actin mutations Y166C and M305L involved in hypertrophic cardiomyopathy.Mammalian Actins: Isoform-Specific Functions and Diseases.
P2860
Q21266678-A2B756CA-FF35-4D19-9751-FD1D2FB27299Q24292820-02A0940B-7985-4D0D-8A9C-F7FFD6F684FDQ24543264-AB7A7B69-636E-46C8-9C05-A4E7A21E69C1Q24546532-45793ABD-0AF7-4BF7-9A6C-1DCE05678C55Q24646242-7B278C0C-3FE8-4023-9FDB-B2668A1E6B8EQ24650132-562A9E5D-4B04-4293-9DA6-0132080F6149Q24804053-500FC2CF-7285-4182-8F73-60D5F36A6D7FQ26753842-CE500633-49DC-496A-987E-68FCFC365715Q27317239-B55F6912-BBDB-4A1E-9C59-AA2CD55D2612Q27336425-C02820D3-1CA0-4171-8701-30CEF5D1ED09Q28253185-5849FAA5-92D4-4A94-BBBD-AD00EF817D22Q28749118-AD5811CB-33A7-470F-8AF6-E6C65BEA3C96Q30421422-528219EC-2FE0-465A-9EC7-6BC223F5B129Q30454015-11E79A77-7E9C-4A5B-862A-575B868D3C03Q30482720-ACC53DE6-0235-4E76-9521-52B5FE290FC1Q30484106-373169D1-C142-4F86-9E88-6676B7D2942CQ30488416-CB535C9E-A1C9-4968-A841-19185811DE17Q30489007-BCD89950-9DAB-4EC4-BC73-3193AF46C1F0Q30495585-01C62A6F-440F-4DE5-BF54-7036A78A583DQ30990855-5E25ABBC-9EBF-4122-ABE3-3904916C1F79Q33303929-0DC36A7C-C1BE-4801-B0F7-C437B5868C14Q33594961-7387FD7E-1778-40D9-B0A0-FFC967D17438Q33877056-8F608A3F-A6BB-4374-BEE0-E4723BFA1D22Q34338789-D56A6CFA-6EE0-4553-A8BA-DD2C956DED74Q34907205-171BA997-0F9F-4F9A-A8BF-DA827589894BQ34989619-0225B701-29E1-4B84-9591-38EFA6828FA5Q35285518-53363DE3-1E66-4C33-B347-4BD391B24569Q35813847-396A1B55-BBAC-4EF9-AF58-DFE7845E1A5FQ35923507-B2FAADE4-65A0-4BBC-B17A-1C5AEC690D0EQ36543753-B6CFC5DE-B9FF-45B7-BFEA-E2779EBEDFB5Q37776676-0BA2C882-2F13-46FE-9B06-4D26BF97FDE5Q38178411-61A8C6DE-BB6A-40F4-8B04-5AFB158B05D2Q38191504-9CA0A32A-54A1-42E8-9154-E9D090DFFB9CQ38384722-06750C90-A3AF-472A-99AF-22911ED04D74Q38953810-3CEA4E84-95B4-448D-A00C-0ED1EF6AF735Q39638600-19406AA6-77A6-4609-AD89-A850DF2672D2Q40316456-AC6AEFDA-6AFE-4E3A-A54E-FEF898CE0FD5Q44405356-5AA7576B-9C25-4742-BA9F-B6A3200A4245Q47696386-EF270B0A-323A-4E9B-8242-4EA8C0E725E7Q49145326-8FCF21FE-590C-4DCF-B04C-FB0FAFBE8E37
P2860
A mutation in the gamma actin 1 (ACTG1) gene causes autosomal dominant hearing loss (DFNA20/26)
description
2003 nî lūn-bûn
@nan
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
A mutation in the gamma actin ...... inant hearing loss (DFNA20/26)
@ast
A mutation in the gamma actin ...... inant hearing loss (DFNA20/26)
@en
A mutation in the gamma actin ...... inant hearing loss (DFNA20/26)
@nl
type
label
A mutation in the gamma actin ...... inant hearing loss (DFNA20/26)
@ast
A mutation in the gamma actin ...... inant hearing loss (DFNA20/26)
@en
A mutation in the gamma actin ...... inant hearing loss (DFNA20/26)
@nl
prefLabel
A mutation in the gamma actin ...... inant hearing loss (DFNA20/26)
@ast
A mutation in the gamma actin ...... inant hearing loss (DFNA20/26)
@en
A mutation in the gamma actin ...... inant hearing loss (DFNA20/26)
@nl
P2093
P2860
P356
P1476
A mutation in the gamma actin ...... inant hearing loss (DFNA20/26)
@en
P2093
C W R J Cremers
E M R De Leenheer
E van Wijk
F P M Cremers
M H Kemperman
P L M Huygen
P2860
P304
P356
10.1136/JMG.40.12.879
P407
P577
2003-12-01T00:00:00Z